Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

3(50.0%)

Phase 4

2(33.3%)

N/A

1(16.7%)

6Total

Phase 2(3)

Phase 4(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00214734Completed

ADVATE Post Authorization Safety Surveillance

Role: collaborator

NCT00299988Phase 2Terminated

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Role: collaborator

NCT02668978Phase 4Completed

SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial Using HEMOPATCH

Role: collaborator

NCT02314325Phase 4Unknown

Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens

Role: collaborator

NCT01989260Not ApplicableUnknown

Post-operative Ovarian Adhesion Study in Women With Endometriosis

Role: collaborator

NCT00533793Phase 2Completed

Adjunctive Therapy to Treat Tibial Shaft Fractures

Role: collaborator

NCT01320514Unknown

Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift

Role: collaborator

NCT00471939Phase 2Completed

Safety and Efficacy of I-020502 in Meshed Skin Autografting

Role: collaborator

All 8 trials loaded